Diagnostic utility of zinc protoporphyrin to detect iron deficiency in Kenyan preschool children: a community-based survey
Emily M Teshome, Andrew M Prentice, Ayşe Y Demir, Pauline E A Andang'o, Hans Verhoef, Emily M Teshome, Andrew M Prentice, Ayşe Y Demir, Pauline E A Andang'o, Hans Verhoef
Abstract
Background: Zinc protoporphyrin (ZPP) has been used to screen and manage iron deficiency in individual children, but it has also been recommended to assess population iron status. The diagnostic utility of ZPP used in combination with haemoglobin concentration has not been evaluated in pre-school children. We aimed to a) identify factors associated with ZPP in children aged 12-36 months; b) assess the diagnostic performance and utility of ZPP, either alone or in combination with haemoglobin, to detect iron deficiency.
Methods: We used baseline data from 338 Kenyan children enrolled in a community-based randomised trial. To identify factors related to ZZP measured in whole blood or erythrocytes, we used bivariate and multiple linear regression analysis. To assess diagnostic performance, we excluded children with elevated plasma concentrations of C-reactive protein or α1-acid glycoprotein, and with Plasmodium infection, and we analysed receiver operating characteristics (ROC) curves, with iron deficiency defined as plasma ferritin concentration < 12 μg/L. We also developed models to assess the diagnostic utility of ZPP and haemoglobin concentration when used to screen for iron deficiency.
Results: Whole blood ZPP and erythrocyte ZPP were independently associated with haemoglobin concentration, Plasmodium infection and plasma concentrations of soluble transferrin receptor, ferritin, and C-reactive protein. In children without inflammation or Plasmodium infection, the prevalence of true iron deficiency was 32.1%, compared to prevalence of 97.5% and 95.1% when assessed by whole blood ZPP and erythrocyte ZPP with conventional cut-off points (70 μmol/mol and 40 μmol/mol haem, respectively). Addition of whole blood ZPP or erythrocyte ZPP to haemoglobin concentration increased the area-under-the-ROC-curve (84.0%, p = 0.003, and 84.2%, p = 0.001, respectively, versus 62.7%). A diagnostic rule (0.038689 [haemoglobin concentration, g/L] + 0.00694 [whole blood ZPP, μmol/mol haem] >5.93120) correctly ruled out iron deficiency in 37.4%-53.7% of children screened, depending on the true prevalence, with both specificity and negative predictive value ≥90%.
Conclusions: In young children, whole blood ZPP and erythrocyte ZPP have added diagnostic value in detecting iron deficiency compared to haemoglobin concentration alone. A single diagnostic score based on haemoglobin concentration and whole blood ZPP can rule out iron deficiency in a substantial proportion of children screened.
Trial registration: ClinicalTrials.gov NCT02073149 (25 February 2014).
Keywords: Child; Erythrocyte protoporphyrin; Inflammation; Iron deficiency; Kenya; Malaria; Plasmodium; Preschool; Zinc protoporphyrin.
Conflict of interest statement
Competing interestsThe authors declare that they have no competing interests.
Publisher’s NoteSpringer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures
References
- Erythrocyte protoporphyrin testing; approved guideline. NCCLS document C42-A. National Committee for Clinical Laboratory Standards: Wayne, PA; 1996.
- Assessing the iron status of populations, 2nd ed. Report of a joint World Health Organization/Centers for Disease Control and Prevention technical consultation on the assessment of iron status at the population level (Geneva, Switzerland: 6–8 April 2004). Geneva, Switzerland: World Health Organization; 2007.
- UN Children’s Fund/UN University/World Health Organization: Iron deficiency anaemia: assessment, prevention, and control. a guide for programme managers. Document reference WHO/NHD/01.3. Geneva, Switzerland: World Health Organization; 2001.
- Mwangi MN, Maskey S, Andango PE, Shinali NK, Roth JM, Trijsburg L, et al. Diagnostic utility of zinc protoporphyrin to detect iron deficiency in Kenyan pregnant women. BMC Med. 2014;12:229. doi: 10.1186/s12916-014-0229-8.
- Teshome EM, Andang o PEA, Osoti V, Terwel SR, Otieno W, Demir AY, Prentice AM, Verhoef H. Daily home fortification with iron as ferrous fumarate versus NaFeEDTA: a randomised, placebo-controlled, non-inferiority trial in Kenyan children. BMC Med. 2017; [in press]
- WHO Multicentre Growth Reference Study Group . WHO child growth standards: length/height-for-age, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age: methods and development. Geneva: World Health Organization; 2006.
- Hastka J, Lasserre J, Schwarzbeck A, Strauch M, Hehlmann R. Washing erythrocytes to remove interferents in measurements of zinc protoporphyrin by front-face hematofluorometry. Clin Chem. 1992;38(11):2184–2189.
- Hastka J, Lasserre J, Schwarzbeck A, Hehlmann R. Central role of zinc protoporphyrin in staging iron deficiency. Clin Chem. 1994;40(5):768–773.
- Serum ferritin concentrations for the assessment of iron status and iron deficiency in populations. Document reference WHO/NMH/NHD/MNM/11.2. Geneva, Switzerland: World Health Organization; 2011.
- Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Document reference WHO/NMH/NHD/MNM/11.1. Geneva, Switzerland: World Health Organization; 2011.
- Abraham K, Muller C, Gruters A, Wahn U, Schweigert FJ. Minimal inflammation, acute phase response and avoidance of misclassification of vitamin a and iron status in infants—importance of a high-sensitivity C-reactive protein (CRP) assay. Int J Vitam Nutr Res. 2003;73(6):423–430. doi: 10.1024/0300-9831.73.6.423.
- Suchdev PS, Namaste SML, Aaron GJ, Raiten DJ, Brown KH, Flores-Ayala R. On behalf of the BRINDA working group. Overview of the biomarkers reflecting inflammation and nutritional determinants of anemia (BRINDA) project. Adv Nutr. 2016;7(2):349–356. doi: 10.3945/an.115.010215.
- Bland JM, Altman DG. Measurement error proportional to the mean. BMJ. 1996;313(7049):106. doi: 10.1136/bmj.313.7049.106.
- Royston P, Altman DG, Sauerbrei W. Dichotomizing continuous predictors in multiple regression: a bad idea. Stat Med. 2006;25(1):127–141. doi: 10.1002/sim.2331.
- Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez J-C, Müller M. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics. 2011;12:77. doi: 10.1186/1471-2105-12-77.
- Altman DG, Machin D, Bryant TN, Gardner MJ (eds.). Statistics with confidence, 2nd ed. London, BMJ Books; 2000. (including CIA software).
- Suchdev PS, Ruth LJ, Earley M, Macharia A, Williams TN. The burden and consequences of inherited blood disorders among young children in western Kenya. Matern Child Nutr. 2014;10(1):135–144. doi: 10.1111/j.1740-8709.2012.00454.x.
- Tsang BL, Sullivan KM, Ruth LJ, Williams TN, Suchdev PS. Nutritional status of young children with inherited blood disorders in western Kenya. Am J Trop Med Hyg. 2014;90(5):955–962. doi: 10.4269/ajtmh.13-0496.
- Atkinson SH, Rockett K, Sirugo G, Bejon PA, Fulford A, O'Connell MA, Bailey R, Kwiatkowski DP, Prentice AM. Seasonal childhood anaemia in West Africa is associated with the haptoglobin 2-2 genotype. PLoS Med. 2006;3(5) doi: 10.1371/journal.pmed.0030172.
- Altman DG. Why we need confidence intervals. World J Surg. 2005;29:554–556. doi: 10.1007/s00268-005-7911-0.
- Pepe MS. The statistical evaluation of medical tests for classification and prediction. Oxford: Oxford University Press; 2003.
Source: PubMed